CLINICAL_TRIALS
trial_result
· 2026-04-08
Clinical Trial Update: Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus [Phase 2]
Summary
This document reports an active Phase 2 placebo-controlled trial evaluating ESK-001 for active systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alumis Inc | Conditions: SLE | Phase 2 | Status: ACTIVE_NOT_RECRUITING